Coronavirus and Other Respiratory Viruses Division (CORVD)
Our Mission
To improve the health of people and communities by preventing illness, disability, and death from respiratory viruses through public health science and practice in the United States and globally.
Our Organization
Office of the Director (OD)
Coordinates the program, policy, and science activities of the four CORVD branches and provides leadership for programmatic activities.
Laboratory Branch
Develops and implements laboratory methods for the detection and characterization of novel, emerging, and known respiratory viruses.
Surveillance & Prevention Branch
Conducts epidemiologic studies on respiratory virus infection, transmission, outcomes, and effectiveness of treatment and prevention to inform clinical and public health actions.
Epidemiology Branch
Monitors trends in medically attended illness, disease burden, and vaccine effectiveness for coronavirus and other respiratory viruses to inform vaccine policy and other prevention strategies.
Global Branch
Implements and monitors the performance of respiratory virus surveillance systems and surveys around the globe, through training, ongoing technical support, laboratory strengthening, and continual monitoring of program performance.
Division Topics
- Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2)
- Other coronaviruses
- Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-1)
- Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
- Seasonal Human Coronaviruses
- Respiratory Syncytial Virus (RSV)
- Adenoviruses
- Rhinoviruses & respiratory enteroviruses
- Human Metapneumovirus (HPMV)
- Human Parainfluenza Viruses (HPIV)
- Parvoviruses
- Novel & emerging respiratory viruses